Jim Carmack is head of capital markets for MedMen Enterprises, the nation’s preeminent cannabis company and the most recognized brand in the emerging marijuana industry.
Mr. Carmack is responsible for developing and implementing MedMen’s investment strategy, including capital raise, acquisitions, mergers, joint ventures and corporate structuring. Prior to joining MedMen, Mr. Carmack served as managing director and head of equity sales and trading at Imperial Capital, a global investment banking services company. He also held leadership positions at New York-based global banking and investment firm Jefferies & Company rising through the ranks in 26 years.
MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry as it moves from its gray market legacy to a fully regulated, legitimate and commercially viable market. MedMen is also one of the nation’s largest financial supporters of progressive marijuana legalization efforts at local, state and federal levels.